Abstract
The use of rapamycin and thalidomide in a patient with metastatic gastroesophageal carcinoma, which led to disease stability associated with a significant tumor marker response and improved clinical quality of life, is reported.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have